摘要:
One aspect of the present invention relates to heterocyclic compounds that bind to bcl proteins and inhibit Bcl function. Another aspect of the present invention relates to compositions comprising a heterocyclic compound of the invention. The present invention provides methods for treating and modulating disorders associated with hyperproliferation, such as cancer.
摘要:
One aspect of the present invention relates to heterocyclic compounds that bind to bcl proteins and inhibit Bcl function. Another aspect of the present invention relates to compositions comprising a heterocyclic compound of the invention. The present invention provides methods for treating and modulating disorders associated with hyperproliferation, such as cancer.
摘要:
Provided herein are compounds of formula (I) or pharmaceutically acceptable salts, solvates or prodrugs thereof, or mixtures thereof, wherein Z1, Z2, X1, X2, X3, R1, R2 R3, m and n are defined herein. Also provided are pharmaceutically acceptable compositions that include a compound of formula I and a pharmaceutically acceptable excipient. Also provided are methods for treating FAAH-mediated disorders comprising administering to a subject in need thereof a therapeutically effective amount of a compound or composition of the present invention.
摘要:
Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.
摘要:
Provided herein are compounds of formula (I) or pharmaceutically acceptable salts, solvates or prodrugs thereof, or mixtures thereof, wherein Z1, Z2, X1, X2, X3, R1, R2 R3, m and n are defined herein. Also provided are pharmaceutically acceptable compositions that include a compound of formula I and a pharmaceutically acceptable excipient. Also provided are methods for treating FAAH-mediated disorders comprising administering to a subject in need thereof a therapeutically effective amount of a compound or composition of the present invention.
摘要:
Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.
摘要:
One aspect of the present invention relates to solution-phase approaches to GPI synthesis. Another aspect of the present invention relates to key building blocks, and syntheses thereof, useful for GPI assembly. Yet another aspect of the invention relates to an automated method for the synthesis of GPIs and fragments thereof.
摘要:
A method is provided for inspecting a plurality of parts with an electronic measurement device and a processing system. The method includes a step of creating surface geometry maps of the parts utilizing the electronic measurement device, where each part was manufactured utilizing the manufacturing device. Geometric part models of the parts are generated from the surface geometry maps. The part models can subsequently be analyzed to determine whether a manufacturing device that manufactured the plurality of parts manufactures parts that comply with a part design specification.
摘要:
A damper seal received in a cavity of a turbine blade located between a platform and a retention shelf damper seal according to an exemplary aspect of the present disclosure includes, among other things, a central body portion having a first end region, an opposing second end region, and a width. The damper seal further includes a first portion extending from the first end region of the central body portion, and a first end region of the first portion includes first outwardly extending tabs that define a first enlarged portion that has a first width greater than the width of the central body portion and a second portion extending from the opposing second end region of the central body portion.
摘要:
A method for manufacturing an investment casting core uses a metallic blank having a thickness between parallel first and second faces less than a width and length transverse thereto. The blank is locally thinned from at least one of the first and second faces. The local thinning forms a taper on a leading portion of the RMC. The blank is through-cut across the thickness. The blank is inserted into the leading portion into a slot in a pre-formed ceramic core.